SLC9A1 and cancer: Consequently, the new, potent and highly selective NHE1 inhibitors - mainly Cariporide, Phx-3 and Compound 9t - appear predestined to be taken advantage of as a new and highly selective therapeutic “magic bullets” in probably most types of human cancer [51,263,276-278].